Drug Information

Drug General Information
Drug ID
D02PGP
Former ID
DNC002361
Drug Name
PU3
Drug Type
Small molecular drug
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [531690]
Therapeutic Class
Anticancer Agents
Formula
C19H25N5O3
Canonical SMILES
CCCCN1C(=NC2=C1N=CN=C2N)CC3=CC(=C(C(=C3)OC)OC)OC
InChIKey
TUOSCZDRWRYPRS-UHFFFAOYSA-N
PubChem Compound ID
448965
PubChem Substance ID
584457, 833616, 7890100, 10300273, 14926545, 36890664, 46393360, 46505689, 46515673, 79104572, 103333767, 104640217, 137004924, 140569505, 160965922, 162510948, 180391587, 196376681, 208011941, 228701608, 244563085
Target and Pathway
Target(s) Heat shock protein HSP90 Target Info Inhibitor [536886]
References
Ref 531690Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers. Biochim Biophys Acta. 2012 Mar;1823(3):742-55.
Ref 536886Recent advances in Hsp90 inhibitors as antitumor agents. Anticancer Agents Med Chem. 2008 Oct;8(7):761-82.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.